The resistance of B-CLL cells to DNA damage–induced apoptosis defined by DNA microarrays

作者: Laurent Vallat , Henri Magdelénat , Helene Merle-Béral , Peggy Masdehors , Gabrielle Potocki de Montalk

DOI: 10.1182/BLOOD-2002-06-1743

关键词: Major histocompatibility complexDNA microarrayGene expression profilingBiologyMolecular biologyMicroarray analysis techniquesDNA damageGeneticsGeneMicroarrayGene expression

摘要: B-cell chronic lymphoid leukemia (BCLL) is a highly heterogeneous human malignancy, presumably reflecting specific molecular alterations in gene expression and protein activity that are thought to underlie the variable disease outcome. Most B-CLL cell samples undergo apoptotic death response DNA damage. However, clinically distinct aggressive subset of completely resistant vitro irradiation-induced apoptosis. We therefore addressed 2 series microarray analyses on 4 sensitive 3 compared their patterns before after stimuli. Data analysis pointed out 16 genes whose varied at least 2-fold specifically cells. validated these selected by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) 7 confirmed altered level 15 additional not included analysis. In this manner, 11 tested, 13 were found be for all samples: nuclear orphan receptor TR3, major histocompatibility complex (MHC) class II glycoprotein HLA-DQA1, mtmr6, c-myc, c-rel, c-IAP1, mat2A, fmod up-regulated, whereas MIP1a/GOS19-1 homolog, stat1, blk, hsp27, ech1 down-regulated. some cases, profile may dependent status p53. Some encode general factors but also exhibit specificities could potentially linked development malignancies (MIP1alpha, mtmr6). Taken together, our data define new markers subsets might clinical relevance.

参考文章(49)
Hélène Merle-Béral, Karim Maloum, Satoshi Ömura, Henri Magdelénat, Jozo Delic, Peggy Masdehors, Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes. Blood. ,vol. 96, pp. 269- 274 ,(2000) , 10.1182/BLOOD.V96.1.269
M Hanada, D Delia, A Aiello, E Stadtmauer, JC Reed, bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia Blood. ,vol. 82, pp. 1820- 1828 ,(1993) , 10.1182/BLOOD.V82.6.1820.1820
K S Sellins, J J Cohen, Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. Journal of Immunology. ,vol. 139, pp. 3199- 3206 ,(1987)
Taghi Manshouri, Hagop Kantarjian, Mohammad Haidar, Susan O'Brien, Michael Keating, Susan Lerner, Petr Starostik, Emil J Freireich, Maher Albitar, Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Research. ,vol. 58, pp. 4552- 4557 ,(1998)
Michael Keating, Carlo M. Croce, John C. Reed, Maher Albitar, Debora Rasio, ATM mutations in B-cell chronic lymphocytic leukemia Cancer Research. ,vol. 59, pp. 24- 27 ,(1999)
Xuefeng Ling, Salar Kamangar, Michelle L. Boytim, Zvi Kelman, Philip Huie, Shu-Chen Lyu, Richard K. Sibley, Jerard Hurwitz, Carol Clayberger, Alan M. Krensky, Proliferating Cell Nuclear Antigen as the Cell Cycle Sensor for an HLA-Derived Peptide Blocking T Cell Proliferation Journal of Immunology. ,vol. 164, pp. 6188- 6192 ,(2000) , 10.4049/JIMMUNOL.164.12.6188
Andrew R. Pettitt, Paul D. Sherrington, Grant Stewart, John C. Cawley, A. Malcolm R. Taylor, Tatjana Stankovic, p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutation Blood. ,vol. 98, pp. 814- 822 ,(2001) , 10.1182/BLOOD.V98.3.814